APA (7th ed.) Citation

Puig, J., Falcó, V., Miranda, C., Ruiz, F., Olalla, J., Rivero, À., . . . Rovira, D. Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)—a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: Study protocol. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Puig, Jordi, et al. Exploring the Acceptability, Appropriateness, Feasibility and Satisfaction of an Implementation Strategy for Out-of-HOspital Administration of the Long-Acting Combination of Cabotegravir and Rilpivirine as an Optional Therapy for HIV in Spain (the HOLA Study)—a Hybrid Implementation-effectiveness, Phase IV, Double-arm, Open-label, Multicentric Study: Study Protocol. BMJ Publishing Group.

MLA (9th ed.) Citation

Puig, Jordi, et al. Exploring the Acceptability, Appropriateness, Feasibility and Satisfaction of an Implementation Strategy for Out-of-HOspital Administration of the Long-Acting Combination of Cabotegravir and Rilpivirine as an Optional Therapy for HIV in Spain (the HOLA Study)—a Hybrid Implementation-effectiveness, Phase IV, Double-arm, Open-label, Multicentric Study: Study Protocol. BMJ Publishing Group.